Background: Experimental studies showed that controlled variable ventilation (CVV) yielded better pulmonary function compared to non-variable ventilation (CNV) in injured lungs. We hypothesized that CVV improves intraoperative and postoperative respiratory function in patients undergoing open abdominal surgery. Methods: Fifty patients planned for open abdominal surgery lasting >3 h were randomly assigned to receive either CVV or CNV. Mean tidal volumes and PEEP were set at 8 ml kg À1 (predicted body weight) and 5 cm H 2 O, respectively. In CVV,
without recruitment manoeuvres and PEEP. In contrast, a more recent randomized controlled trial showed that recruitment manoeuvres and higher PEEP are not effective in reducing postoperative pulmonary complications (PPCs) when a protective V T is applied, while deteriorating haemodynamics. 10 However, those studies were conducted with conventional non-variable V T, and different results could result if lungs were submitted to variable mechanical ventilation. In fact, a ventilatory strategy using breath-by-breath randomly variable V T , which mimics some of the characteristics of spontaneous breathing in healthy subjects, has been shown to improve lung function and reduce pulmonary damage in different experimental models of lung injury. 11e13 Those effects have been attributed mainly to the capability of variable ventilation to recruit and stabilize lungs, 14 which might be superior to conventional manoeuvres. 15 In the present study, we compared controlled mechanical ventilation with variable vs non-variable protective mean V T [controlled variable ventilation (CVV) and non-variable ventilation (CNV), respectively] in patients undergoing open abdominal surgery. We hypothesized that CVV compared to CNV improves respiratory function in the intraoperative and postoperative periods.
Methods
The study protocol was approved by the institutional review board at the Medical Faculty of the Technische Universit€ at Dresden, Germany (EK 174052011), registered at clinicaltrials.gov (NCT01683578), and published in detail elsewhere. 16 The study was conducted in accordance with the declaration of Helsinki and the principles of good clinical practice.
Screening
Patients planned for elective open abdominal surgery at the University Hospital Dresden, Germany were screened during regular anaesthesia preoperative evaluations over a period of 12 months.
Inclusion and exclusion criteria
Patients were enrolled in the study if they fulfilled all of the following inclusion criteria: 1) expected duration of surgery >3 h; 2) ASA classification II or III; 3) expected tracheal extubation in the operation room; 4) written informed consent to participate in the study. Patients were excluded if they had at least one of the following criteria: 1) chronic lung diseases other than chronic obstructive pulmonary disease Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages A and B, and untreated bronchial asthma; 2) BMI >40 kg m À2 ; 3)
hypersensitivity or allergy to one of the drugs administered during the study or to drugs with similar chemical structure; 4) participation of the patient in another clinical trial within the preceding 30 days; 5) history of substance abuse or any other mental status possibly affecting capacity of giving informed consent; 6) pregnancy or breastfeeding; 7) suspected low patient compliance; 8) contraindication for magnetic resonance imaging (MRI); and 9) mechanical ventilation within the last 30 days.
Randomisation and methods against bias
Randomisation was performed with closed envelopes, and using a fixed 1:1 ratio with blocks of 2 Â 10, 3Â6, and 3Â4 patients. Bias was avoided by means of a modified triple blind design. Patients and assessors of the postoperative period were unaware of the treatment, and the intraoperative investigator was blinded to the preoperative and postoperative measurements.
Outcomes
The primary endpoint was the forced vital capacity (FVC) on postoperative Day 1. As shown in previous investigations, deteriorations in FVC are strongly associated with the development of PPCs after abdominal surgery 8 and well correlated with radiological abnormalities in lung computed tomography (CT) scans after radiotherapy. 17 Secondary endpoints were oxygenation (PaO 2 /F I O 2 ) during surgery, changes of spatial distribution of ventilation measured by electrical impedance tomography (EIT) during surgery and postoperatively, the partial pressure of oxygen in peripheral capillary blood (PcO 2 ), peak expiratory flow (PEF), forced expiratory volume in the first second (FEV 1 ) and amount of atelectasis measured with MRI tomography on postoperative Day 1, and occurrence of PPCs within the first 5 days after surgery. PPCs were measured as a collapsed composite including mild or severe respiratory failure, bronchospasm, suspected pulmonary infection, development of acute respiratory distress syndrome, and presence of atelectasis, pulmonary infiltrates, pleural effusion, pulmonary oedema, and pneumothorax according to chest Xray, as previously described by our group. 18, 19 A further secondary endpoint was the occurrence of postoperative extrapulmonary complications within the first 5 days after surgery, including development of systemic inflammatory response syndrome, sepsis, severe sepsis or septic shock, extrapulmonary infection, coma, acute myocardial infarction, acute renal failure, disseminated intravascular coagulation, hepatic failure, and gastrointestinal bleeding.
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Preoperative visit (preoperative day)
On the day preceding surgery, informed consent was obtained, demographic data were recorded, and spirometry, EIT measurements, and peripheral capillary blood gas analysis performed to retrieve baseline data. In addition, the Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) score was calculated as described 18 and validated 19 elsewhere.
Briefly, in ARISCAT, age, preoperative peripheral oxygen saturation (SpO 2 ) in room air, occurrence of respiratory infection in the 30 days preceding surgery, presence of preoperative anaemia, duration of surgery, and type of procedure (elective vs emergency) are determined, and patients classified as mild, moderate, or high risk of developing PPCs.
Day of surgery
On the operation day, preparation for anaesthesia and surgery was conducted according to local standard of care. MRI of the lungs was performed in spontaneously breathing subjects in the supine position prior to premedication. PBW, and the distribution of values followed a Gaussian distribution with coefficient of variation (CV) at 30%, as described by our group in detail elsewhere. 13 A CV of 30% was chosen because it has been shown to improve 20 EIT measurements were repeated in semi-recumbent patients at 30 degrees after induction of anaesthesia (post-induction), and after surgical wound closure (post-closure) before the end of anaesthesia.
Arterial blood gases were measured hourly throughout surgery. Haemodynamic and respiratory data were recorded from the monitoring system and the ventilator, respectively. Amounts of infused drugs and fluids, and blood loss and urine output were recorded.
General clinical management during surgery was performed according to local standards. At the end of surgery, the infusion of neuromuscular blocking agent was stopped. When reversal of muscular paralysis was detected (train-of-four¼4), the infusion of i.v. anaesthetics was stopped and a bolus of 10 ml ropivacaine 0.3% with sufentanil 0.5 mg ml À1 given through the epidural catheter for analgesia, as appropriate. Patients were subsequently extubated upon adequate spontaneous breathing activity and reflexes, and transferred to the post-anaesthesia or intensive care unit, as clinically indicated.
Postoperative period
Lung MRI was repeated on postoperative Day 1 in spontaneously breathing patients in the supine position. Spirometry, EIT, blood sampling, and peripheral capillary gasometry in room air, and documentation of pain using a visual analogue scale, were performed on postoperative days 1, 3, and 5, and on the day of hospital discharge. The in-hospital length of stay was also determined.
Spirometry
Pulmonary functional tests were performed at the bedside by using a commercial spirometer (MicroLoop, CareFusion, Wurmlingen, Germany), while the patient was in a seated, comfortable position. The patient placed a clip over the nose and breathed through the mouth into a tube connected to the spirometer. First, the patient breathed in deeply, and then exhaled as quickly and forcefully as possible into the tube. The test was repeated three times and the best of the three results was considered to be the measure of lung function. 22 FVC, PEF, and FEV 1 were measured, and the ratio between FEV 1 and FVC was calculated by internal algorithms of the spirometer.
Respiratory variables
Respiratory signals were acquired continuously from the mechanical ventilator at a sample frequency of 125 Hz (Evita XL4Lab, Dr€ ager Medical). Extraction of respiratory variables was performed offline from 10 min recordings of airway flow and pressure (P aw ). The elastance and resistance of the respiratory system (E rs and R rs , respectively) were calculated using the equation of motion, as shown in Equation (1):
where V(t) is volume, _ VðtÞ is air flow at given time point t, and P aw,0 corresponds to the total P aw at end-expiration.
The percentage of volume-dependent elastance %E 2 , a surrogate to assess tidal recruitment, linear expansion, and hyper-inflation, was calculated as explained elsewhere. 23 
Blood gases and peripheral oxygen saturation
Arterial and peripheral capillary blood samples were analysed using a standard blood gas analyser (ABL 80 Flex; Radiometer, Copenhagen, Denmark). SpO 2 was measured using a standard monitor (MP 50, Philips, B€ oblingen, Germany). Intraoperatively, haemodynamic variables were measured using a standard monitor (MP 70, Philips).
Lung imaging
EIT was performed with the PulmoVista® 500 (Dr€ ager Medical). Images of the EIT device containing 32Â32 pixels were recorded at a rate of 50 frames s À1 during 2 min for offline analysis.
Data were low-pass filtered (30 min
À1
) in order to exclude heartbeat-induced impedance changes. The highest and lowest limits of the area containing changes in impedance [region of interest (ROI)] were determined. Normalized impedances were calculated as impedance per pixel normalized to the minimal impedance within the ROI. For each breath and all pixels, local impedance changes were calculated as normalized impedance at end-inspiration minus normalized impedance at end-expiration. The centre of ventilation (i.e. the geometrical centre of the EIT image as three dimensional object with x and y as coordinates on the left-right and ventral-dorsal axis and z as local impedance change) was determined as previously described. 24 Its position along the ventral-dorsal axis, expressed as relative distance from ventral, represents a surrogate for the distribution of ventilation along this axis, which can be interpreted as the median height across that gradient. The centre of ventilation generates a single number from an EIT image and therefore facilitates the comparison of EIT recordings during different patient conditions. Native MRI sequences of lungs using T2 (HASTE: TR/ TE¼1000 ms 98 ms À1 ; 360 ms per slice) and T1 (VIBE: TR/ TE¼1000 ms 98 ms À1 ; 12 s per volume Â 2) were obtained during inspiratory breath holds. Investigators blinded to the study groups manually segmented the whole lungs and the atelectasis zones using the software ITK-Snap. 25 Volumetric measurements were then performed using routines developed by our group for CT, 26 which were adapted for MRI.
Analysis of markers of inflammation
Approximately 4 ml blood samples were taken from arterial or venous indwelling catheters using sterile tubes containing ethylenediamine tetra-acetic acid (Monovette, Sarstedt AG & Co., Nü mbrecht, Germany) at the selected time points. Tubes were centrifuged at 2000 rpm for 15 min, and plasma aliquots of approximately 1 ml collected and stored at À80 C until analysis. The levels of tumour necrosis factor-alpha (TNF-a), interleukin (IL)-6 and IL-8 in plasma were determined using commercial enzyme-linked immunosorbent assay kits and according to the manufacturer's instructions (Thermo Fisher Scientific Affymetrix, Inc., San Diego, CA, USA).
Data and safety monitoring
Two independent experts in the field (Professor Benedikt Pannen, University of Dü sseldorf, Dü sseldorf, Germany, and Professor Alsparlan Turan, Cleveland Clinic, Cleveland, OH, USA) served as data quality and safety officers. They monitored adherence to the study protocol, quality of data collection and processing, and safety issues. Serious adverse events, and unexpected and related or possibly related adverse events were reported to the internal review board of the Medical Faculty and the University Hospital Dresden, and to the data quality and safety officers. Regular checks for plausibility and protocol adherence were performed according to good clinical practice guidelines.
Statistics
Sample size calculation was based on a previous study using FVC as a measure of postoperative pulmonary function following general anaesthesia. 27 In the present study, effect size was estimated as 1.086 (72% vs 60% of expected normal value, 12% absolute mean difference, relative standard deviation of approximately 11.05%). Alpha was defined as 0.05 and study power as 0.95. Using a two-tailed Mann-Whitney-U-test, sample size calculation yielded 25 patients per group. Analysis was performed using GPower (Software Version 3.1.3, University of Dü sseldorf).
Normally distributed variables are shown as mean and standard deviation, or median and interquartile ranges otherwise. Categorical variables are given as n (%). Plasma levels of markers of inflammation were analysed after logarithmic transformation to achieve normal distribution. Analyses followed the intention-to-treat principle. The primary endpoint (FVC on Day 1), was assessed using an unpaired Student's t-tests. For time-dependent variables, group, time, and group Â time effects were tested with general linear model statistics, whereby values at induction or preoperative served as covariate, as appropriate. In case of missing values, imputation was conducted with the last value carried forward. The P values for multiple comparisons were adjusted according to the Bonferroni procedure for both univariate and multivariate tests. 
Results
The CONSORT checklist of items was fulfilled and the respective diagram of the trial is presented in Figure 1 . The primary endpoint was analysed in 23 patients in the CNV group (one patient was still intubated on postoperative Day 1 and one patient refused to perform spirometry on postoperative Day 1) and 24 patients in CVV group (one patient withdrew consent to the study on postoperative Day 1). Demographic data, including patients' characteristics, type of surgery, and postoperative analgesia, are depicted in Table 1 . Patients in both groups showed moderate to high risk of developing PPCs according to the ARISCAT score (Table 1) . Intraoperatively, dosages of anaesthetics and neuromuscular blocking agent, BIS levels, and fluids, dosages of vasoactive drug, blood loss, and urine output did not differ between CNV and CVV (Table S1 , web supplement). No serious adverse events were observed.
FVC did not differ significantly between groups on postoperative Day 1 in CVV and CNV (Fig. 2) . As depicted in Table 2 , Fig 1. CONSORT Diagram. Patient flow in the PROtective VARiable ventilation (PROVAR) study according to the CONSORT guidelines. 188 patients were screened for eligibility and 50 were finally enrolled in the trial. 25 patients were randomly assigned to receive either controlled variable ventilation or controlled non-variable ventilation, respectively. One patient in CVV and CNV groups refused being submitted to further measurements after days 1 and 3, respectively. One patient in CNV group was still intubated at day 1, so that the primary endpoint could not be assessed. Therefore intention to treat (ITT) analysis was performed in 24 patients in CVV and 23 patients in CNV group, respectively. except to FEV 1 /FVC, pulmonary function tests including FVC and oxygenation deteriorated from the preoperative to the postoperative period, but did not differ between groups.
During CVV, the CV of V T , and maximum V T , peak P aw , and % E 2 were higher, while minimum V T , peak P aw , and %E 2 , were lower compared to CNV (Table 3) . Mean P aw , E RS , and R RS , and gas exchange and haemodynamics did not differ significantly between groups (Table 4 ). Figure S1 (web supplement) shows maps of ventilation of representative patients and respective centres of ventilation. The centre of ventilation, as measured by EIT, shifted from dorsal to ventral lung zones during mechanical ventilation (Fig. S2, web supplement) . In the postoperative phase, the centre of ventilation returned approximately to the same level as before induction, with no difference between groups. Figure S3 (web supplement) depicts preoperative and postoperative lung MRI scans of representative patients in each group. As shown in Table S2 (web supplement), total lung volume decreased, while non-aerated lung volume increased from the preoperative to the postoperative Day 1, but values did not differ significantly between groups. On postoperative Day 1, median percentages of non-aerated lung volume were as low as 2% and 3% in CNV and CVV, respectively.
Plasma levels of TNF-a, IL-6, and IL-8 are shown in Table S3 (web supplement). IL-6 and IL-8 first increased following surgery, and decreased thereafter until discharge (Table S3 , web supplement), but did not differ between CNV and CVV.
All patients, irrespective of type of mechanical ventilation, developed PPCs, whereby pleural effusion was the most frequent one, and single events did not differ significantly between groups (Table S4 , web supplement). The incidence of extrapulmonary postoperative complications also did not differ between groups. The average pain visual analogue scale for thoracic pain, abdominal pain at rest, and abdominal 
Discussion
In this single-centre randomised controlled trial in patients undergoing open abdominal surgery and at increased risk for PPCs, we found that CVV compared with CNV: 1) did not improve FVC on postoperative Day 1; 2) led to similar intraoperative respiratory function; 3) did not affect FEV 1 , PEF, FEV 1 /FVC, oxygenation, the distribution of ventilation, or the amount of non-aerated lung volume in the postoperative period; 4) did not result in different plasma levels of IL-6 and IL-8; and 5) yielded comparable incidences of pulmonary and extra-pulmonary complications. To our knowledge, this is the first randomised controlled trial addressing the effects of intraoperative CVV on postoperative respiratory function and lung morphology using advanced lung-imaging techniques. We tested CVV, because experimental evidence showed it is effective in recruiting lungs and leads to less impairment of haemodynamics than traditional recruitment manoeuvres. 28 Furthermore, variable V T has been shown to improve lung-protective ventilation strategies in experimental models of acute lung injury. 13, 29 To assess the isolated effects of CVV, we maintained mean V T and PEEP comparable between groups. A mean V T of 8 ml kg À1 PBW and a PEEP of 5 cm H 2 O were chosen, because those values are within the respective ranges recommended for protective mechanical ventilation during general anaesthesia in non-injured lungs. 30 We investigated patients undergoing open abdominal surgery lasting longer than 3 h because of the higher risk of deteriorating lung function postoperatively. 19 Our observation that the primary endpoint, namely FVC on postoperative day 1, FEV 1 , PEF, and FEV 1 /FVC in the postoperative period did not differ between CVV than CNV, might be explained by different mechanisms. Variable ventilation was not associated with any signs of substantial recruitment during surgery, as suggested by comparable respiratory mechanics and gas exchange. Furthermore, during emergence from anaesthesia, higher inspiratory fractions of oxygen were used, and might have reverted any possible recruitment effect. In addition, we cannot rule out that atelectasis formation was minor in our patients during surgery, as suggested by relatively low amounts of atelectatic lung volume on postoperative Day 1.
The fact that oxygenation and respiratory mechanics did not improve during CVV, as compared to CNV, is in contrast with the results of a randomized trial that reported better lung function during CVV in patients undergoing abdominal aortic aneurysmectomy. 31 Differences could be explained by several factors. First, in that study, 31 PEEP was set at 0 cm H 2 O, which might have contributed to more pronounced reduction of lung volume and higher amounts of atelectasis during non-variable ventilation. Second, the type of surgery required the use of abdominal packs and retractors, likely exacerbating the formation of atelectasis. Third, an F I O 2 of 0.6 was used during surgery, possibly further increasing atelectasis. Intraoperatively, the centre of ventilation, as measured by EIT, shifted from dorsal to ventral areas, possibly due to the paralysis of the diaphragm. However, this shift was comparable in both groups, supporting the hypothesis that relevant recruitment did not occur during CVV. In fact, maximum V T , peak airway pressure (P peak ) and %E 2 indicate that CVV resulted in distending pressures potentially high enough to recruit lungs. It has been shown that airway pressures higher than 30 cm H 2 O are required to open up certain atelectatic regions of non-injured lungs. 32 During CVV, airway pressures as high as 30 cm H 2 O were achieved in some patients, but the average peak P aw was lower than that threshold. Furthermore, since we used volume-controlled ventilation with constant inspiratory flow, the inspiratory plateau pressure was certainly lower. It has been suggested that CVV promotes long lasting lung recruitment in the experimental setting. 33 The lack of improvement in E rs during CVV evidences that the volumepressure relationship of the respiratory system was rather linear, precluding substantial lung recruitment. 28 In view of these facts, we hypothesize that intraoperative atelectasis was relatively low in our patients, which is partially supported by Values are given as mean (SD). Pulmonary function tests refer to expected normal values of patients (%). Blood gas analysis was performed in room air. General linear model statistics were used to assess group, time and group*time effects. A P value <0.05 was considered statistically significant. CNV, Controlled non-variable ventilation; CVV, controlled variable ventilation; FEV 1 , forced expiratory volume in the first second; FVC, forced vital capacity; PEF, peak expiratory flow; SpO 2 , peripheral oxygen saturation measured by pulse oximetry; PcO 2 , partial pressure of oxygen in capillary blood, measured by blood gas analysis. 
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CVV was not associated with increased need for fluids or vasoactive drugs compared to CNV. Previous studies reported acute deterioration in arterial blood pressure during more conventional recruitment manoeuvres when PEEP was set at 10 cm H 2 O 8 or 12 cm H 2 O. 10 The likely explanation is that CVV is not associated with long lasting increases in airway pressure, and does not impair the venous return as much as other types of recruitment manoeuvre. The observation that plasma levels of inflammatory cytokines, and the incidence of pulmonary and extrapulmonary complications did not differ between CVV and CNV is in line with the pulmonary function data. However, it should be emphasised that this study was not testing the effects of the different ventilatory strategies on clinical outcomes and was underpowered to do so.
Possible clinical implications
The present study reinforces the concept that differentiated mechanical ventilation approaches, herein accomplished by means of variable ventilation, on top of protective low V T and moderate PEEP, do not improve postoperative respiratory function, lung morphology, or outcome. This observation suggests that periodic intraoperative recruitment does not add to improved postoperative lung function, and is in line with recent meta-analyses showing that low V T 30,37,38 and driving pressure 39 during surgery are the main determinants of lung protection. Future studies addressing variable ventilation in non-injured lungs should avoid the use of patterns resulting in V T values far lower than 6 ml kg À1 , which may jeopardize possible beneficial effects of periodic lung recruitment.
Limitations
Our study has different limitations. First, the present results cannot be extrapolated to other types of surgery, for example laparoscopic and thoracic surgery. Second, we excluded obese patients with BMI>40 kg m À2 , who might be more prone to impairment of respiratory function during and after surgery, possibly benefiting from CVV. Third, the study was not powered for detecting differences in major outcome variables. Fourth, we cannot exclude the possibility that Table 4 Intraoperative gas exchange and haemodynamics
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A P value <0.05 was considered statistically significant. CNV, Controlled non-variable ventilation; CVV, controlled variable ventilation; HR, heart rate; MAP, mean arterial blood pressure; PaO 
Authors' contributions
Collected and analysed data, and drafted the manuscript: P.M.S., A.G. Collected and analysed data, and revised the draft of the manuscript: C.U., T.B., T.K. Collected data, and revised the draft of the manuscript: C.C., K.B., A.I., F.T. Collected and analysed lung imaging data, and revised the draft of the manuscript: A.B., L.B. Collected and analysed respiratory data, and revised the draft of the manuscript: R.H. Designed the study, evaluated the data, and revised the draft of the manuscript: M.J.S., T.K. Designed the protocol for lung imaging and revised the draft of the manuscript: N.A. Designed the study, evaluated the data, and revised the draft of the manuscript: TK. Designed the study, evaluated the data, and drafted the manuscript: P.P., M.G.A.
Declaration of interest
M.G.A., P.M.S., and T.K. have been granted patents on variable pressure support ventilation, which are licensed to Dr€ agerwerk AG, Lü beck, Germany. The other authors declare no conflict of interest.
